What is Summit Therapeutics's interest coverage?

Summit Therapeutics (SMMT) reported interest coverage of -26× in Q4 2024.

What does interest coverage mean?

Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.

Summit Therapeutics SMMT Interest coverage

Interest coverage at other companies

ImmunityBio, Inc.IBRX

-5×-1.1×

Immunovant, Inc.IMVT

-19×+5.0×

IncyteINCY

689.3×+620×

Roivant SciencesROIV

122.5×+104×

Jazz PharmaceuticalsJAZZ

-1.4×-3.2×

Johnson & JohnsonJNJ

24.5×-1.7×

Other financials

Income statement

See full

Revenue-—

Operating income-$65.6M-81.2%

Net income-$189.4M-201%

EPS (diluted)-$0.24-167%

Balance sheet

See full

Cash & equivalents$8.2M+7.2%

Total debt$20.0M+211%

Total equity$545.9M+58.5%

Total assets$647.9M+68.8%

Cash flow

See full

Operating cash flow-$122.3M-99.9%

CapEx$245.0K-41.9%

Free cash flow-$122.5M-99.0%

Valuation

See full

Market cap$10.67B+3.3%

Enterprise value$10.68B+3.4%

Profitability

See full

Operating margin-268,266.8%-272,316pp

Net margin-271,685%-275,966pp

FCF margin-5,931.6%+4,730pp

Returns & leverage

See full

Return on equity-271%-1,725pp

Debt / equity0×0.0×

Current ratio7.4×-3.2×

Where this comes from

Calculated from Summit Therapeutics’s reported figures.

ebit/interest expense=-26×

Based on trailing twelve months.

The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Summit Therapeutics's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Summit Therapeutics's interest coverage?: Summit Therapeutics (SMMT) reported interest coverage of -26× in Q4 2024.
What does interest coverage mean?: Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.